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Abstract
Background: Meprin (EC 3.4.24.18), an astacin-like metalloprotease, is expressed in the epithelium of the intestine and
kidney tubules and has been related to cancer, but the mechanistic links are unknown.
Methodology/Principal Findings: We used MDCK and Caco-2 cells stably transfected with meprina and or meprinb to
establish models of renal and intestinal epithelial cells expressing this protease at physiological levels. In both models E-
cadherin was cleaved, producing a cell-associated 97-kDa E-cadherin fragment, which was enhanced upon activation of the
meprin zymogen and reduced in the presence of a meprin inhibitor. The cleavage site was localized in the extracellular
domain adjacent to the plasma membrane. In vitro assays with purified components showed that the 97-kDa fragment was
specifically generated by meprinb, but not by ADAM-10 or MMP-7. Concomitantly with E-cadherin cleavage and
degradation of the E-cadherin cytoplasmic tail, the plaque proteins b-catenin and plakoglobin were processed by an
intracellular protease, whereas a-catenin, which does not bind directly to E-cadherin, remained intact. Using confocal
microscopy, we observed a partial colocalization of meprinb and E-cadherin at lateral membranes of incompletely polarized
cells at preconfluent or early confluent stages. Meprinb-expressing cells displayed a reduced strength of cell-cell contacts
and a significantly lower tendency to form multicellular aggregates.
Conclusions/Significance: By identifying E-cadherin as a substrate for meprinb in a cellular context, this study reveals a
novel biological role of this protease in epithelial cells. Our results suggest a crucial role for meprinb in the control of
adhesiveness via cleavage of E-cadherin with potential implications in a wide range of biological processes including
epithelial barrier function and cancer progression.
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Introduction
Meprin is a zinc metalloendopeptidase of the astacin family,
which was first discovered as an abundantly expressed protease at
the brush border membrane of epithelial cells in the kidney [1]
and the intestine [2]. Meprin consists of two homologous subunits,
meprina and meprinb, which share 42% amino acid sequence
identity. The a and b subunits form homo- or heterodimers
covalently linked via disulfide bonds, as well as higher multimeric
structures resulting from non-covalent association of dimers [3].
Both subunits are synthesized as zymogens and targeted to the cell
surface. The multimers composed of the b subunits are mainly
transmembrane complexes, whereas those composed only of
meprina are secreted, due to an intracellular processing event
that removes the transmembrane anchor [4–6]. Their activation
requires removal of a propeptide by enzymes such as trypsin or
plasmin [7,8]. These proteases cleave a wide range of substrates in
vitro, including bioactive peptides (angiotensins, TGF-a), growth
factors and hormones (gastrin, glucagon) [2,9], cytokines
(monocyte chemoattractant protein-1, IL-1b) [10] and extracellu-
lar matrix proteins (laminin 1 and 5, type IV collagen, fibronectin)
[11,12]. However, meprina and meprinb display different
substrate repertoires and cleavage site specificities [13].
The broad proteolytic activity of meprin indicates multiple
functions in health and disease. Indeed, meprin has been linked to
both cancer and inflammation [14–16]. Expression of meprina
and meprinb has been demonstrated in different types of cancer
cells, including colorectal, breast, osteosarcoma and pancreatic cell
lines [17,18]. Meprina is aberrantly secreted to the stroma in
colorectal cancer [14]. However, the substrates and pathogenetic
role of meprins in cancer are not known. Here we describe the
tumor suppressor E-cadherin as a novel target of meprinb.
E-cadherin is a transmembrane glycoprotein and the principal
component of adherens junctions in epithelial cells. It mediates
homophilic calcium-dependent interactions between adjacent
cells, which are stabilized by intracellular association with the
catenin proteins b-catenin, plakoglobin, p120-catenin and a-
catenin. These associations contribute to the regulation of diverse
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migration [19]. In cancer, downregulation of E-cadherin has been
shown to play a crucial role in the progression of well
differentiated adenoma to invasive carcinoma [20], and E-
cadherin is therefore considered to act as a tumor suppressor [21].
Loss or alteration of E-cadherin has been demonstrated in
adenocarcinomas of many tissues including kidney and intestine
[22–28], and cleavage of E-cadherin has been described as one of
the cellular mechanisms controling its function. For example, the
metalloproteases stromelysin-1 (MMP-3), matrilysin (MMP-7) or
ADAM-10 cleave E-cadherin extracellularly, generating a soluble
fragment that impairs cell-cell adhesion [29,30]. We demonstrate
that meprinb cleaves the ectodomain of E-cadherin, which
correlates with a reduction in intercellular adhesive strength and
cell aggregation in meprinb-expressing cells.
Methods
Antibodies and recombinant proteins
Meprinb-specific and meprina/b-crossreactive rabbit polyclon-
al antibodies were generated using a glutathion S-transferase
fusion protein expressed in E. coli, as previously described [4,31].
Antibodies recognize meprin zymogens and activated forms. Anti-
E-cadherin antibodies used in this study were: DECMA (Sigma,
St. Louis, MO, U.S.A.), SC7870 (Santa Cruz Biotechnology,
Heidelberg, Germany) and C-terminal clone 36 (BD Transduction
Laboratories, San Jose, U.S.A.). Anti-b-catenin (clone 14) and
anti-plakoglobin (clone 15) monoclonal antibodies were from BD
Transduction Laboratories. Monoclonal anti-tubulin antibody
(Clone TUB-1A2) was from Sigma. Horseradish peroxidase-
conjugated anti-rabbit, anti-mouse and anti-rat secondary anti-
bodies were obtained from Amersham Biosciences (Buckingham-
shire, U.K.) and Dako Cytomation (Denmark). Active recombi-
nant meprina and meprinb were purified from a baculovirus
expression system in insect cells as described previously [32].
Purified recombinant human ADAM-10 (active ectodomain
derived from an insect cell expression system) and pro-MMP-7
(expressed in a mouse myeloma cell line) were from R+D Systems,
Abingdon, U. K. Pro-MMP-7 was activated with 1 mM p-amino-
phenylmercuric acetate (AMPA) at 37uC for 1 h.
Cell culture
Culture media and supplements were obtained from Invitrogen
(Basel, Switzerland). Actinonin, bovine trypsin and soybean trypsin
inhibitor were purchased from Sigma. Wild-type MDCK,
MDCKa, MDCKb and MDCKab cells [5–7] were grown in
minimal essential medium (MEM) supplemented with 25 mM
HEPES, 5% fetal bovine serum and 2 mM glutamine. Wild-type
Caco-2 cell subclone ‘‘TC7’’, a generous gift from Prof. Monique
Rousset, and the meprinb-expressing clone ‘‘b21’’ were grown in
Dulbecco’s Modified Eagle Medium (DMEM) supplemented with
20% fetal bovine serum, 2 mM glutamine, 4.5 g/l D-glucose and
non-essential amino acids (100 mM each). Cells were seeded at a
density of 8610
5 on polyethylene terephtalate (PET) cell culture
inserts (4.2 cm
2 growth area, 0.4 mm pore size, from BD
Biosciences, Basel, Switzerland) and incubated in 2 ml apical
medium and 3 ml basolateral medium. Establishment of cell
monolayers was followed by phase contrast microscopy. Prior to
harvesting, subconfluent and confluent cell cultures were incubat-
ed for 24 hours in serum-free medium (Advanced minimum
essential medium, AdvMEM). For meprin in situ activation, cell
cultures were treated with bovine trypsin (10 mg/ml in AdvMEM)
for 30 min, washed twice with phosphate-buffered saline and
subsequently incubated with fresh AdvMEM containing soybean
trypsin inhibitor (20 mg/ml). For in situ meprin inhibition, cells
were incubated with 100 nM actinonin in AdvMEM for 24 hours.
Stable meprinb-expressing Caco-2 cells were generated using
METAfectene transfection reagent (Invitrogen, Basel, Switzerland)
according to the manufacturer’s protocol. Caco-2-TC7 cells were
grown in 6 cm dishes until 50% confluence and subsequently
incubated with 2 ml OPTI-MEM containing the transfection
cocktail with 10 mg meprinb-expression plasmid [7] and 2 mg
pBKCMVneo
r (Stratagene, La Jolla, CA, U.S.A.) for 6 h. Cell
cultures were supplemented with additional 2 ml complete
medium for an overnight incubation, passaged from each 6 cm
dish into five 10 cm dishes and selected in complete medium with
1000 mg/ml and 700 mg/ml geneticin for the two following weeks.
Caco-2 cell clones were harvested using cloning cylinders and
screened for meprinb expression using Western blot analysis.
Preparation of cell lysates, SDS-PAGE and
immunoblotting
Cells were washed twice with phosphate-buffered saline and
lysed on ice in 25 mM Tris-HCl pH 8, 50 mM sodium chloride,
1% IGEPAL (Sigma), 1% sodium deoxycholate (Sigma), with
complete protease inhibitor cocktail EDTA-free (Roche, Basel,
Switzerland) for 45 minutes. Cell debris was removed by
centrifugation and the protein content in the resulting extracts
was determined using the bicinchoninic acid (BCA) protein assay
(Pierce, Rockford, U.S.A.). All chemicals for gel electrophoresis
were obtained from Bio-Rad Laboratories AG (Reinach, Switzer-
land). Equal protein amounts (15 mg) were solubilized by boiling in
Laemmli buffer, subjected to electrophoresis under reducing
conditions on 10% SDS-polyacrylamide gels and subsequently
electroblotted onto a polyvinylidene difluoride (PVDF) membrane
(Hybond P, Amersham Biosciences). Subsequent incubations were
done using 25 mM Tris-HCl pH 7, 150 mM sodium chloride,
2.5 mM potassium chloride, 0.1% Tween-20 (TBS-T) at room
temperature. After saturation with TBS-T containing 5% dry
milk, the membrane was incubated with the first antibody
overnight and the appropriate horseradish peroxidase-conjugated
secondary antibody for 2 hours. Immune complexes were
visualized on X-ray films using enhanced chemiluminescence
(ECL Plus, from Amersham Biosciences). The membrane was
stripped in 62.5 mM Tris-HCl pH 6.8, 2% sodium dodecyl sulfate
(SDS), 50 mM dithiothreitol (DTT) on a shaking plate at 65uC for
45 minutes and washed extensively in TBS-T. The efficiency of
stripping was ascertained by exposing a X-ray film on the
membrane prior to reprobing for another target protein. Apparent
molecular weights were determined using a calibration plot with
standard proteins as a reference (broad range SDS-PAGE
Standards, Bio-Rad Laboratories).
Immunoprecipitation
The anti-E-cadherin antibody (DECMA, 6 mg) was preab-
sorbed to 60 ml protein G-Sepharose beads (50% slurry, from
Amersham Biosciences) in 500 ml cytoskeleton (CSK)-buffer
(10 mM piperazine-N,N9-bis(2-ethane-sulfonic acid) pH 6.8,
300 mM sucrose, 50 mM sodium chloride, 3 mM magnesium
chloride, 0.5% (v/v) Triton X-100 (Sigma), 1.2 mM phenyl-
methylsulfonyl fluoride (Sigma), 10 mM sodium pyrophosphate,
20 mM sodium fluoride (Sigma), with complete protease inhibitor
cocktail EDTA-free (Roche)) at 4uC for 2 hours. The beads were
washed twice with 500 ml CSK-buffer, resuspended in CSK-buffer
to create a 50% slurry and combined with precleared 500 mg
cellular protein extract (in 500 ml CSK-buffer) or 1.2 ml cell
culture supernatant. E-cadherin was immunoprecipitated at 4uC
for 4 hours. Supernatants after immunoprecipitation were ana-
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buffer (50 mM Tris-HCl pH 7.5, 1 mM magnesium chloride with
complete protease inhibitor cocktail EDTA-free (Roche), and
either analyzed by SDS-PAGE and Western blotting, or
resuspended in 100 ml meprin assay buffer and divided into
aliquots for in vitro cleavage reactions (see below).
E-cadherin in vitro cleavage assay with human
recombinant meprin, ADAM-10 and MMP-7
Protein extracts from MDCK cells (50 mg) or immunoprecip-
itated E-cadherin were incubated with meprina, meprinb,
ADAM-10 or MMP-7 at 37uC in corresponding optimized assay
buffers supplemented with complete protease inhibitor cocktail
EDTA-free (Roche). The assay buffer for cleavage reactions with
meprina and meprinb was 50 mM Tris-HCl pH 7.5, 1 mM
magnesium chloride (Meprin assay buffer) supplemented with
1 mM calcium chloride. Assay buffers for ADAM-10 and MMP-7
were 25 mM Tris-HCl pH 9.0, 2.5 mM zinc chloride, 0.005%
Brij35 and 50 mM Tris-HCl pH 7.5, 10 mM calcium chloride,
150 mM sodium chloride, 0.05% Brij35, respectively. Cleavage
reactions were stopped by adding 10 mM EDTA. Beads were
washed once in corresponding assay buffer. E-cadherin cleavage
fragments were separated on 10% SDS-polyacrylamide gels and
detected by Western blotting.
Immunofluorescence staining and confocal laser
scanning microscopy
MDCK cells grown on filter inserts were washed twice with
phosphate-buffered saline, fixed in 2.5% paraformaldehyde in
phosphate buffer saline for 30 minutes and permeabilized with
0.1% Triton-X-100 in 25 mM Tris-HCl pH 7.5, 140 mM sodium
chloride (TBS) for 5 minutes To retrieve meprinb epitopes,
samples were microwaved in 10 mM citrate-monohydrate,
pH 5.65 for 5 minutes. Subsequent incubations were done in
TBS at room temperature. Slides were blocked in 20% goat or
rabbit normal serum, incubated with primary antibodies directed
against meprinb (1:500) or E-cadherin (DECMA 1:3600) and
appropriate secondary antibodies (AlexaFluor 488-conjugated
anti-rabbit 1:1000 and AlexaFluor 594-conjugated anti-rat
1:400, from Molecular Probes, Invitrogen). Mounted samples
(Vectashield mounting medium, from Vector Laboratories Inc.,
Burlingame, U.K.) were analyzed with Zeiss LSM 510 Meta
coupled to the confocal inverted Zeiss microscope (Axiovert
200 M; lasers: HeNe 633 nm, HeNe 543 nm, and Ar 488 nm,
Zeiss, Feldbach, Switzerland).
Calcium-switch assay
Confluent cell monolayers were subjected to the calcium switch
assay [33] as follows: The cells were seeded onto filter inserts
(8610
5 cells/4.2 cm
2/0.4-mm pore size) and allowed to attach in
Ca
2+-containing DMEM (1.8 mM Ca
2+) until confluence. For the
switch, the cells were rinsed three times with phosphate-buffered
saline and incubated in S-MEM (low Ca
2+ minimum essential
medium for suspension culture) (Invitrogen) which contains less
than 5 mM total Ca
2+,a t3 7 uC for 30 or 120 minutes.
Immediately after these time points, the cells were rinsed twice
with phosphate-buffered saline, fixed in 2.5% paraformaldehyde
and processed for immunofluorescence and confocal microscopy
as described above.
Dispase-based dissociation assay
The assay for measuring cell-cell adhesive strength [34] was
modified as follows: MDCKwt and MDCKab cells were washed
twice in phosphate-buffered saline and incubated in 0.6 ml of
dispase (2.4 U/ml; Roche) for 45 minutes. Released monolayers
were transferred to 15-ml conical tubes, washed once and
resuspended in 0.6 ml phosphate-buffered saline. To apply a
mechanical stress, the monolayers were subjected to 20 pipettings
with an automatic pipette. After 1 minute, released single cells
were counted in a 10 ml- aliquot. One well of each triplicate was
treated with trypsin instead of dispase, to determine the total cell
number, which was divided by the mechanically released single
cells. Statistical analysis was performed on three separate
experiments and statistical significance (t-test) was defined as
P,0.05.
Cell aggregation assay
The assay was adapted from a previous report [35]: Cells were
resuspended at 5610
5 cells/ml in AdvMEM with or without
100 nM actinonin. Six 30-ml drops of the cell suspension were
cultured as ‘‘hanging drops’’ on the inner surface of the lid of a 12-
well culture dish. To prevent evaporation, 0.5 ml phosphate-
buffered saline was placed in the bottom of each well. After an
overnight incubation at 37uC, cell aggregates that had formed at
the drop meniscus were photographed with a Nikon DIAPHOT
300 inverted microscope.
Results
Meprinb generates a 97-kDa E-cadherin fragment in
epithelial cells
To investigate the fate of E-cadherin in the presence of meprin,
we used MDCK cells as a well-established and thoroughly
characterized model of renal tubular epithelial cells. MDCK cells
stably expressing meprina (MDCKa) [7], meprinb (MDCKb), or
both meprina and meprinb (MDCKab) [5] were compared with
parental wild-type cells (MDCKwt). The use of meprin-transfected
epithelial cells was motivated by the lack of available cell lines
expressing endogenous meprin at significant levels. Cell lysates
were prepared from cells harvested at preconfluent and confluent
growth stages and analyzed on Western blots. E-cadherin was
cleaved in MDCKab cells, generating an E-cadherin fragment of
97 kDa (Figure 1A). Activation of meprin by in situ trypsin
treatment of cell cultures increased the cleavage of E-cadherin and
resulted in the accumulation of the 97-kDa fragment at the
expense of the 120-kDa mature form (Figure 1A). The trypsin
treatment did not affect E-cadherin in control MDCKwt cells.
Conversely, inhibition of meprin activity by actinonin decreased
the amount of the 97-kDa E-cadherin fragment (Figure 1A).
Western blot analysis of MDCK cells expressing individual
subunits revealed that meprinb but not meprina mediated the
cleavage of E-cadherin (Figure 1B). Meprinb protein levels in
transfected MDCK cells were similar to endogenous levels in
mouse kidney homogenates, excluding an artifact due to
inappropriately high expression of the protease (Figure 1C).
We confirmed these observations in Caco-2 cells, a human
colon carcinoma cell line which differentiates into a polarized
enterocyte-like cell type and endogenously expresses meprina [14].
E-cadherin expression was analyzed by Western blotting in the
parental subclone Caco-2-TC7 in comparison to a cell clone stably
expressing meprinb (Caco-2-b21). As in MDCKab cells, the 97-
kDa fragment was generated in meprinb-expressing Caco-2 cells,
which was enhanced after in situ activation by trypsin (Figure 1D).
Similar levels of the 97-kDa E-cadherin fragment were detected in
preconfluent and confluent cell cultures (Figure 1A, D). Taken
together the findings implicate meprinb in the proteolytic
processing of endogenous E-cadherin.
Meprinb Processes E-Cadherin
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To corroborate the direct cleavage of E-cadherin by meprinb,
we incubated MDCKwt cell lysates with different concentrations
of the purified active recombinant protease. To avoid interference
of cellular proteases, cell lysates were supplemented with protease
inhibitors targeting all protease families except metalloproteases.
The in vitro reaction was stopped at different time points and E-
cadherin was analyzed by Western blotting. In the absence of
meprinb, only the mature form of E-cadherin was detectable
(Figure 2A, lanes 1, 5, 9). At 5 ng/ml meprinb, a fragment was
generated that corresponded in size to the 97-kDa fragment
previously observed in MDCKab and MDCKb lysates (Figure 2A,
lanes 2, 6, 10). At 50 ng/ml meprinb, the 97-kDa fragment
accumulated at the expense of the mature form (Figure 2A, lanes
3, 7, 11). At the highest concentration of meprinb, the full length
E-cadherin was no more detectable, and in addition to the 97-kDa
fragment, a fragment of 60 kDa was also generated (Figure 2A,
lanes 4, 8, 12). The assay gave identical results in the presence of
the broad spectrum caspase inhibitor z-VAD-FMK (not shown),
excluding any implication of these proteases known to cleave E-
cadherin during apoptosis [36].
To exclude the possibility that a protease in the cell lysate
processed E-cadherin downstream of meprinb, we repeated the in
vitro cleavage assay with immunopurified E-cadherin. Figure 2B
shows that the 97-kDa E-cadherin fragment was generated upon
addition of 50 ng/ml and 500 ng/ml purified meprinb to the
beads with immunoprecipitated E-cadherin.
E-cadherin has been previously reported to be cleaved
extracellularly by MMP-7 and ADAM-10 [29,30,37]. We
therefore compared the cleavage of E-cadherin with active
recombinant forms of these two proteases at different concentra-
tions in vitro both in MDCK cell lysate (Figure 2C) and after
immunoprecipitation on beads (Figure 2D). The generated E-
cadherin fragment was slightly larger than the one generated by
meprinb, indicating that MMP-7 and ADAM-10 at the enzyme
concentrations used in our assay target a cleavage site C-terminal
to the meprinb site. These data provide evidence that the 97-kDa
E-cadherin fragment is a different and specific product of the
processing by meprinb.
Meprinb colocalizes with E-cadherin in MDCK cells
In polarized cells, meprinb and E-cadherin are normally
targeted to apical [5] and lateral membrane domains, respectively.
However, our data suggest that both proteins are in contact at a
certain time point. We therefore analyzed the distribution of E-
cadherin and meprinb in MDCKab cells in subconfluent and
confluent cultures by immunofluorescence and confocal laser
scanning microscopy (CLSM). In cells grown to preconfluent
Figure 1. E-cadherin is truncated in MDCK and Caco-2 cells expressing meprinb. (A,B) Wild-type and meprin-expressing cells were grown
on transwell filter inserts, in situ treated with trypsin or actinonin (meprin activator and inhibitor, respectively), or left untreated. Immunoblot analysis
of indicated cell lysates was done with a monoclonal antibody directed against the EC1 domain at the N-terminus of E-cadherin (DECMA). An
additional 97-kDa fragment of E-cadherin was detected in meprinb-expressing cells. Blots were stripped and reprobed for meprin and tubulin. (C)
Protein levels of meprinb were similar in meprinb-expressing MDCK cells and homogenates of whole mouse kidneys (C57Bl/6 strain). 15 mg of total
protein extracts were analyzed on immunoblots. (D) E-cadherin is processed in meprinb-expressing Caco-2 cells (b21) but not in parental TC7 Caco-2
cells.
doi:10.1371/journal.pone.0002153.g001
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intercellular junctions, with a concomitant pool of E-cadherin
being present intracellularly (Figure 3A). Meprinb was detected at
the apical domain and in addition at lateral borders (Figure 3A).
The lateral immunostaining for meprinb was partially colocalized
with the signal for E-cadherin as evidenced by the yellow color in
the merged picture and the orthogonal projections shown in the x–
z and y–z planes (Figure 3A). The partial colocalization of
meprinb and E-cadherin at lateral membranes indicates that E-
cadherin is accessible to the protease. After formation of a
confluent monolayer, the two proteins appeared to be restricted to
apical and lateral domains, respectively, without microscopically
distinguishable overlap (Figure 3B). However, the biochemical
data shown above indicate that E-cadherin and meprinb may still
interact transiently for the processing to occur.
Molecular mapping of the E-cadherin cleavage site
To define the cleavage site of E-cadherin by meprinb,
immunoblots of MDCKwt and MDCKab lysates were reprobed
on the same blot with three different region-specific antibodies
(Figure 4A). The mature form of E-cadherin and the 97-kDa
fragment were both detected by the N-terminal DECMA antibody
(Figure 4B). The SC7870 antibody, raised against the last
extracellular domain of E-cadherin (EC5) and the juxtamembra-
nous region, did not detect the 97-kDa fragment under conditions
that revealed an equally strong signal for the mature 120-kDa form
Figure 2. In vitro cleavage of E-cadherin by purified recombinant active meprinb. (A) MDCKwt cell lysates were incubated with different
concentrations of meprinb for the indicated times. Cleavage products were analyzed on Western blots using an anti-E-cadherin antibody (DECMA).
Processed E-cadherin in MDCKab cells are shown in comparison. (B) E-cadherin was first immunoprecipitated from MDCKwt cell lysates and
subsequently incubated on the beads with recombinant meprinb at the indicated concentration for 40 minutes. E-cadherin cleavage fragments in
eluates from the beads were analyzed on immunoblots using the monoclonal N-terminal antibody (DECMA). Samples of MDCKwt and MDCKab cell
lysates were loaded as reference. (C,D) Specific generation of the 97-kDa E-cadherin fragment by meprinb, but not MMP-7 and ADAM-10. MDCKwt
cell lysates (C) or immunoprecipitated E-cadherin on beads (D) were incubated for 1 hour or overnight with increasing concentrations of
recombinant active meprinb, MMP-7 and ADAM-10 (0.0125 nM, 0.125 nM and 1.25 nM).
doi:10.1371/journal.pone.0002153.g002
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that SC7870 epitopes are lost in the 97-kDa fragment.
Considering the size of the cleaved fragment, it can be concluded
that the cleavage site is located close to the epitopes covered by the
SC7870 antibody and in vicinity of the transmembrane domain.
Consistently, the cytoplasmic BD36 antibody failed to detect the
97-kDa E-cadherin fragment, or any smaller residual fragment
(Figure 4B), further indicating that the cytosolic tail of E-cadherin
may be degraded after cleavage by meprinb.
The 97-kDa E-cadherin fragment is not released from cells
Cleavage of E-cadherin by meprinb may lead to the release of a
soluble fragment in culture media. We therefore immunoprecip-
itated E-cadherin from conditioned culture media of confluent cell
cultures (Figure 5). MDCK cells constitutively released small
amounts of a 80-kDa E-cadherin fragment irrespective of the
presence of meprin. However, the 97-kDa E-cadherin fragment
was not detectable, indicating that it may be retained by the cells.
E-cadherin processing by meprinb affects its cytoplasmic
binding partners b-catenin and plakoglobin but not a-
catenin
The assembly of E-cadherin with the catenin proteins precedes
the linkage of the adherens junctions to the cytoskeleton, which
participates in the stabilization of cell-cell adhesions [38–40]. We
investigated whether E-cadherin cleavage affected their integrity.
Figure 6 shows that in MDCK and Caco-2 cells expressing
meprinb, b-catenin and plakoglobin were both cleaved into two
smaller fragments (Figure 6A and B). In contrast, a-catenin was
not affected in meprinb-expressing cells (Figure 6C).
Uniform distribution of meprinb over the cell surface in
non-polarized MDCK cells
To further confirm the possibility of meprinb localization to
lateral membranes, we determined meprinb distribution upon
perturbation of cell-cell adhesion and cell polarization after
withdrawing Ca
2+ from the medium. MDCKab cells were grown
to confluence, immunostained with a meprinb-specific antibody,
and analyzed by confocal microscopy. Meprin localization in cells
grown in Ca
2+-containing medium (control condition) was
compared with cells exposed to Ca
2+-free medium for 30 minutes
and 120 minutes. Initially, meprinb appeared at the apical
membrane domain only (Figure 7, panels a and d), which is in
accordance with previous biochemical studies demonstrating an
apical targeting of this isoform [5]. After 30 minutes of incubation
in Ca
2+-free medium, the cells rounded up and meprinb
relocalized to lateral membrane domains (Figure 7, panels b and
e). After 120 minutes, meprinb redistributed all over the plasma
membrane (Figure 7, panels c and f). After 6 hours of recovery in
normal medium, meprinb relocalized to the apical membrane
domain (not shown). These results exemplify that meprinb may
distribute all over the cell surface upon loss of cell polarization,
which may expose additional substrates that normally would be
inaccessible to the protease. Such potential substrates include
proteins that establish cell-cell contacts. Therefore, in the presence
of meprinb cleaving E-cadherin (see above), the formation of cell-
cell contacts may be affected.
Reduced cell-cell adhesion and formation of multicellular
aggregates in meprinb-expressing cells
To determine the functional consequence of meprinb-mediated
E-cadherin for intercellular adhesiveness, we performed two
different assays. To measure the adhesive strength between cells,
we applied mechanical stress to a cell monolayer detached with
dispase [34]. Figure 8A shows that the adhesive strength between
MDCKab cells was significantly decreased by 50% as compared
to MDCKwt cells. We next evaluated the effect of meprinb on
aggregation of suspended cells in a hanging drop assay [35].
MDCKwt and MDCKa cells formed large aggregates, whereas
much smaller aggregates were observed with MDCKab and
Figure 3. Meprinb is partially colocalized with E-cadherin in MDCKab cells. The distribution of meprinb and E-cadherin was analyzed by
double immunostaining and CLSM in preconfluent (A) and confluent (B) monolayers. Pictures shown are single optical sections in the x–y axis.
Corresponding orthogonal sections in the x–z and y–z axis are shown beside. Arrows in the merged picture indicate were meprinb and E-cadherin
colocalize (evidenced by the yellow color). Bar=10 mm.
doi:10.1371/journal.pone.0002153.g003
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confirm the implication of meprinb in the reduction of cell-cell
aggregation, we repeated the experiment in the presence of the
meprin inhibitor actinonin. Under these conditions, MDCKab
and MDCKb cells formed aggregates with a size comparable to
MDCKwt and MDCKa cells (Figure 8B, panels e–h). Identical
results were observed with Caco-2 wild-type and meprinb–
expressing cells (see Figure 8B, panels i–l). These findings
demonstrate that intercellular adhesion is reduced in meprin b-
expressing epithelial cells.
Discussion
Previous studies indicate an involvement of the metalloprotease
meprin in inflammation and cancer [41]. However, the molecular
mechanisms implicating meprin in these processes are unknown.
Here, we provide evidence that meprinb targets and processes E-
cadherin thus affecting intercellular adhesion. In particular, our
study shows that, in two different epithelial cell types, the
expression of meprinb induced the cleavage of E-cadherin,
generating a specific 97-kDa fragment. Cleavage of E-cadherin
was enhanced upon in situ activation of cell-surface expressed
meprin by limited trypsin treatment, and inversely decreased after
inhibition of meprin by actinonin, indicating that the proteolytic
activity was required for cleavage of E-cadherin.
We demonstrate the direct and specific cleavage of E-cadherin
in an in vitro cleavage assay with purified recombinant active
Figure 5. The 97-kDa E-cadherin fragment is not released from
cells. E-cadherin was immunoprecipitated with the N-terminal
antibody (DECMA) from conditioned media of MDCK cells. Fresh
medium was used as a negative control (ct). Whole cell lysates were
loaded on the same gel as reference. A soluble 80-kDa E-cadherin
fragment was detected in conditioned media irrespective of meprin
expression (arrowhead). No specific signal was detectable at 97-kDa.
Additional bands were present in all immunoprecipitations including
the fresh medium sample and thus were attributable to background.
doi:10.1371/journal.pone.0002153.g005
Figure 4. Molecular mapping of the cleavage site of E-cadherin by meprinb. (A) Schematic representation of E-cadherin and antibody
epitopes. a: DECMA, b: SC7870, c: BDclone 36. S: Signal peptide, Pro: Propeptide, EC: Cadherin-domain, TM: transmembrane domain. (B) Protein
extracts from MDCKwt and MDCKab cell lines were resolved by SDS-PAGE and analyzed by immunoblot using antibodies a–c. The same membrane
was successively stripped and reprobed.
doi:10.1371/journal.pone.0002153.g004
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ADAM-10, which are both expressed in epithelial cells and
previously have been shown to target E-cadherin [29,30], only
meprinb yielded the 97-kDa fragment, which therefore appears to
be a specific cleavage product. ADAM-10 and MMP-7 both
produced slightly larger fragments. In a very similar in vitro
cleavage assay reported previously, MMP-7 generated several
cleavage products of E-cadherin with apparent molecular weights
down to 80 kDa [29]. However, the enzyme concentrations used
in that reported experiment (minimum concentration 20 ng/
100 ml) were significantly higher than in our assay (maximum
concentration 1.25 nM equals 3.5 ng/100 ml). With the low
enzyme concentrations used in this study, MMP-7 generated only
a single product. Therefore, MMP-7 displays variable cleavage
efficiency at different sites in E-cadherin and we may have missed
less efficient cleavage sites that would yield the additional MMP-7
specific fragments. Thus, multiple proteases may target a range of
sites in E-cadherin with variable cleavage efficiencies, which co-
determine the final E-cadherin cleavage products.
In contrast to meprinb, meprina was not implicated in the
cleavage of E-cadherin, as the 97-kDa E-cadherin fragment was
not detected in lysates of cells expressing only the a subunit. This
was also supported by the failure of purified recombinant active
meprina to generate the 97-kDa E-cadherin fragment in vitro (not
shown). Different substrate and peptide bond specificities between
the two isoforms have been previously described [13], and their
differential activity towards E-cadherin corroborates the distinct
functions of both subunits.
The cleavage of E-cadherin by meprinb is unique. Although
truncated E-cadherin fragments with similar size were described in
several reports, these were generated by intracellular proteases
[42–44]. In contrast, we defined the cleavage site in the
ectodomain close to the plasma membrane (see Figure 4). This
is consistent with our observation that a recombinant soluble form
of E-cadherin lacking the transmembrane region was not cleaved
by meprinb in vitro (not shown). It is also consistent with a
structural model of meprinb that has been proposed recently on
the basis of cross-linking experiments [45]. According to this
model, meprinb folds back onto itself, positioning the catalytic
domain close to the plasma membrane [45].
Prior studies have shown the extracellular cleavage of E-
cadherin by different metalloproteases, which led to the release of
soluble fragments. A soluble 95-kDa E-cadherin fragment
generated by an unidentified metalloprotease was found in
cultured cancer cells [44]. In prostate and breast cancer cells,
matrilysin (MMP-7) and stromelysin (MMP-3) have been shown to
generate a soluble 80-kDa fragment [29,37], and ADAM-10, a
transmembrane protease, controls constitutive and regulated
shedding of E-cadherin in cell cultures of keratinocytes and in
vivo in mouse embryos [30]. Small amounts of the 80-kDa E-
cadherin are also shed from MDCK cells, which was not affected
by meprin (Figure 5) and possibly is mediated by endogenous
Figure 6. The direct binding partners of E-cadherin are
processed in MDCK and Caco-2 cells expressing meprinb. b-
catenin and plakoglobin were analyzed in protein extracts of MDCKwt,
MDCKab, MDCKa and MDCKb cells (A), as well as in Caco-2-TC7 and
Caco-2-b21 cells (B). Two cleaved fragments were detected in lysates of
cells expressing meprinb. a-catenin remained intact (C).
doi:10.1371/journal.pone.0002153.g006
Figure 7. Meprinb distribution in polarized and depolarized MDCKab cells. MDCKab cells were grown to confluence on filter supports in
complete medium and subjected to a Ca
2+-switch (described in experimental procedures). After fixation and immunostaining, meprinb localization
was analyzed by CLSM. Pictures (a–c) are single optical sections (x–y). Corresponding orthogonal sections in the x–z plane are shown below (d–f).
Picture a shows meprinb localization in confluent polarized MDCKab cells. Pictures b+e and c+f show meprinb relocalization 30 minutes and
120 minutes after removal of extracellular Ca
2+. Bar=10 mm.
doi:10.1371/journal.pone.0002153.g007
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data indicate that the 97-kDa E-cadherin fragment is retained by
the cells, where it possibly interferes with the function of full length
E-cadherin at the cell surface. For example, the 97-kDa fragment
might modulate the interaction between E-cadherin subunits,
thereby affecting mechanical links as well as intracellular signalling
pathways. There is increasing evidence that E-cadherin triggers
intracellular pathways implicated in growth arrest and differenti-
ation, which depend on the formation of homophilic bonds at the
cell surface [47–49]. In addition, cleavage and subsequent
degradation of the E-cadherin cytoplasmic tail may directly
prevent activation of signaling cascades that depend on the
recruitment of cytoplasmic effectors, such as phospatidylinositol-3
kinase, to the E-cadherin tail.
The processing of E-cadherin by MMPs or ADAM-10 has been
shown to lead to the generation of cell-associated C-terminal E-
cadherin fragments of approximately 40 kDa, which was accom-
panied by increased b-catenin-mediated signaling. In contrast, no
such fragment was detectable with a C-terminal antibody in
meprinb-expressing MDCK cells, indicating that it is prone to
degradation. We also show that in parallel with the disappearance
of the C-cytosolic tail of E-cadherin in meprinb-expressing cells,
the intracellular binding partners b-catenin and plakoglobin were
also processed, but not a-catenin, which is not directly linked to E-
cadherin. Previous reports have shown that these proteins are
cleaved by caspases 3 and 8 [50] during apoptosis, and by calpain
in prostate and mammary tumor cells [51], and it is therefore
possible that these intracellular proteases are implicated in
meprinb-expressing MDCK cells as well.
As a consequence of the disruption of the cadherin/catenin
complex, the intercellular adhesion in meprinb-expressing cells
was significantly weakened, as demonstrated by the decrease in
cell-cell contact strength and cell-cell aggregation. The 97-kDa E-
cadherin fragment itself, the degradation of the cytoplasmic region
of E-cadherin after cleavage by meprinb, as well as the specific
proteolytic processing of its direct binding partners may account
for the impaired cell-cell adhesion. This is supported by several
reports where the absence of the catenin binding domain was
shown to abolish the adhesive activity of E-cadherin [39,52].
The transition from preconfluent to confluent cell cultures
recapitulates the development of epithelial cell polarity and
concomitant sequestering of proteins to specific membrane
domains [53]. This explains the different localization patterns of
meprinb and E-cadherin during progression to fully established
cell polarity and has direct implications for the cellular
compartment of meprinb-mediated E-cadherin processing. In
subconfluent cultures of incompletely polarized MDCK cells both
partners colocalize at lateral membranes, where E-cadherin
processing may occur (Figure 3). However, in confluent cultures
of fully polarized cells, the 97-kDa fragment is also present, despite
the spatial restriction of meprinb and E-cadherin to separate
membrane domains. As the formation of a stable protein complex
between a protease and its substrate is an exception, we speculate
that processing of E-cadherin in polarized cells occurs in a
transient protein complex in the absence of detectable colocaliza-
tion at the microscopic level. Sorting of E-cadherin in polarized
cells displays a high degree of plasticity. For instance, direct
delivery of E-cadherin to lateral membrane in MDCK cells occurs
only two days after reaching the confluent stage, and before that, a
substantial part of the newly synthesized E-cadherin pool is
delivered to and transiently resides at the apical side [53].
Therefore, the cellular sorting routes for E-cadherin and meprinb
overlap substantially in polarized MDCK cells, which may
facilitate their transient interaction.
This is the first report implicating meprinb in the control of the
adhesive function in epithelial cells. The regulation of epithelial
cell-cell adhesion is of utmost importance to maintain tissue
architecture and to prevent cell invasion during pathological
conditions [19,54], and E-cadherin is a primordial factor often
repressed during transition from adenoma to carcinoma [20,55].
Therefore, cleavage of E-cadherin by meprinb may be a means to
Figure 8. Meprinb affects intercellular adhesion. (A) Cell-cell
contact strength was measured using the dispase assay (described in
experimental procedures). The graph shows the mean values +/2 SD
from 3 independent experiments. *=p,0.05. (B) Cell aggregation assay
with MDCK cell lines (a–h) and Caco-2 cell lines (i–l). Hanging drops of
cell suspensions were incubated overnight. Representative pictures of
three independent experiments with each condition in 6 replicates are
shown. Cells expressing meprinb form smaller aggregates (b, d, j
compared to a, c, i). The presence of actinonin (right panels) in the
resuspension medium reverted the phenotype of meprinb expressing
cells (f, h, l) without having an effect in the other cell lines (e, g, k).
doi:10.1371/journal.pone.0002153.g008
Meprinb Processes E-Cadherin
PLoS ONE | www.plosone.org 9 May 2008 | Volume 3 | Issue 5 | e2153reduce E-cadherin-mediated cell-cell-interactions. The redistribu-
tion of meprinb to the basolateral membrane of MDCK cells upon
Ca
2+-switch-induced depolarization is of interest, because the
polarization status of epithelial cells is perturbed in diverse
pathological conditions, including ischaemic disease, inflammation
and cancer. An aberrant targeting of meprinb in such conditions
may have important functional consequences as it may enhance
access to basolateral substrates, including E-cadherin. A cancer-
specific meprinb transcript, meprinb9, has been shown to be
expressed from an alternative promoter region that includes
multiple oncogene binding sites in cancer cells of mammary,
colonic and pancreatic origin [18,56]. Hence, the expression of
meprinb in cancer coupled to perturbed protein sorting and high
E-cadherin processing efficiency indicate that this protease can
modulate cancer cell functions.
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